10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
βGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
94PubMed Papers
21Diseases
0Drugs
3Pathogenic Variants
FUNCTIONAL ROLETranscription Factor
CLINICALOMIM Disease Gene
DATA QUALITYβ Experimental GO Evidenceβ Swiss-Prot Reviewed
protein bindingpositive regulation of transcription by RNA polymerase IIhematopoietic stem cell differentiationpositive regulation of stem cell differentiationosteogenesis imperfectaosteogenesis imperfecta, recessiveskeletal dysplasiacraniodiaphyseal dysplasia
SP7 (Sp7 transcription factor) is a critical transcriptional activator essential for osteoblast differentiation and bone formation 1. SP7 functions downstream of RUNX2, which induces SP7 expression to convert RUNX2+ osteoprogenitors into RUNX2+SP7+ preosteoblasts 12. SP7 then drives the differentiation of preosteoblasts into mature osteoblasts without enhancing their proliferation 1. The transcription factor binds to G/C-rich DNA sequences and regulates major bone matrix protein genes including Col1a1 1. Beyond its canonical role in osteoblast differentiation, SP7 has been identified to control osteocyte dendrite formation through its target gene osteocrin 3. SP7 is necessary for osteocytes to acquire sufficient cellular processes, and reduction of these processes results in osteocyte apoptosis and cortical porosity 2. Mutations in SP7 cause osteogenesis imperfecta in rare cases, with defective osteocyte morphology observed in humans carrying SP7R316C mutation 31. Recent genome-scale analyses have revealed both canonical and non-canonical modes of SP7 action, identifying additional target genes and upstream regulatory factors that control skeletal development and maintenance 4.
1
SP7 is essential for osteoblast differentiation, functions downstream of RUNX2, and converts preosteoblasts to osteoblasts
PMID: 393375872
RUNX2 induces SP7 expression and SP7 is needed for osteocyte process formation
PMID: 393525503
SP7 controls osteocyte dendrite formation through osteocrin and SP7R316C mutation causes defective osteocyte morphology
PMID: 347253464
Recent genome-scale analyses revealed canonical and non-canonical modes of SP7 action
PMID: 35628456β Limited data available β This gene has 4 indexed publications. Summary and analysis may be incomplete.
osteogenesis imperfectaOpen Targets
osteogenesis imperfecta, recessiveOpen Targets
skeletal dysplasiaOpen Targets
craniodiaphyseal dysplasiaOpen Targets
osteogenesis imperfecta type 4Open Targets
atrial fibrillationOpen Targets
breast cancerOpen Targets
spondylometaphyseal dysplasia, A4 typeOpen Targets
odontochondrodysplasia 1Open Targets
kyphomelic dysplasiaOpen Targets
metatropic dysplasiaOpen Targets
Metaphyseal chondrodysplasia, Schmid typeOpen Targets
Schmid metaphyseal chondrodysplasiaOpen Targets
diaphanospondylodysostosisOpen Targets
Osteogenesis imperfecta 12UniProt
NM_001173467.3(SP7):c.810C>A (p.Cys270Ter)Likely pathogenic
Osteogenesis imperfecta type 12
β
βββ2024β Residue 270
NM_001173467.3(SP7):c.359_362del (p.Asp120fs)Likely pathogenic
Osteogenesis imperfecta type 12
ββββ2023β Residue 120
NM_001173467.3(SP7):c.1052del (p.Glu351fs)Pathogenic
not provided|Osteogenesis imperfecta type 12
ββββ2010β Residue 351